ReviewClinical drug investigation2017

Targeted Cancer Therapies and QT Interval Prolongation: Unveiling the Mechanisms Underlying Arrhythmic Complications and the Need for Risk Stratification Strategies.

Rezarta Cuni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.